Carcinoma, Pancreatic Ductal
"Carcinoma, Pancreatic Ductal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Descriptor ID |
D021441
|
| MeSH Number(s) |
C04.557.470.200.025.232.750 C04.557.470.615.132.750 C04.588.274.761.750 C04.588.322.475.750 C06.301.761.750 C06.689.667.625 C19.344.421.750
|
| Concept/Terms |
Carcinoma, Pancreatic Ductal- Carcinoma, Pancreatic Ductal
- Carcinomas, Pancreatic Ductal
- Ductal Carcinoma, Pancreatic
- Ductal Carcinomas, Pancreatic
- Pancreatic Ductal Carcinomas
- Duct-Cell Carcinoma of the Pancreas
- Duct Cell Carcinoma of the Pancreas
- Pancreatic Ductal Carcinoma
- Ductal Carcinoma of the Pancreas
- Pancreatic Duct Cell Carcinoma
- Carcinoma, Ductal, Pancreatic
- Duct-Cell Carcinoma, Pancreas
- Carcinoma, Pancreas Duct-Cell
- Carcinomas, Pancreas Duct-Cell
- Duct Cell Carcinoma, Pancreas
- Duct-Cell Carcinomas, Pancreas
- Pancreas Duct-Cell Carcinoma
- Pancreas Duct-Cell Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Pancreatic Ductal".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Ductal [C04.557.470.200.025.232]
- Carcinoma, Pancreatic Ductal [C04.557.470.200.025.232.750]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Ductal [C04.557.470.615.132]
- Carcinoma, Pancreatic Ductal [C04.557.470.615.132.750]
- Neoplasms by Site [C04.588]
- Digestive System Neoplasms [C04.588.274]
- Pancreatic Neoplasms [C04.588.274.761]
- Carcinoma, Pancreatic Ductal [C04.588.274.761.750]
- Endocrine Gland Neoplasms [C04.588.322]
- Pancreatic Neoplasms [C04.588.322.475]
- Carcinoma, Pancreatic Ductal [C04.588.322.475.750]
- Digestive System Diseases [C06]
- Digestive System Neoplasms [C06.301]
- Pancreatic Neoplasms [C06.301.761]
- Carcinoma, Pancreatic Ductal [C06.301.761.750]
- Pancreatic Diseases [C06.689]
- Pancreatic Neoplasms [C06.689.667]
- Carcinoma, Pancreatic Ductal [C06.689.667.625]
- Endocrine System Diseases [C19]
- Endocrine Gland Neoplasms [C19.344]
- Pancreatic Neoplasms [C19.344.421]
- Carcinoma, Pancreatic Ductal [C19.344.421.750]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Pancreatic Ductal".
This graph shows the total number of publications written about "Carcinoma, Pancreatic Ductal" by people in this website by year, and whether "Carcinoma, Pancreatic Ductal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 2 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 5 | 0 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 8 | 0 | 8 |
| 2016 | 4 | 0 | 4 |
| 2017 | 3 | 1 | 4 |
| 2018 | 5 | 0 | 5 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 6 | 2 | 8 |
| 2022 | 7 | 0 | 7 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Pancreatic Ductal" by people in Profiles.
-
Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
-
Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. Int J Mol Sci. 2024 Apr 02; 25(7).
-
miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. Int J Mol Sci. 2023 Apr 13; 24(8).
-
Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer. Clin Cancer Res. 2022 08 02; 28(15):3176-3178.
-
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Res. 2022 06 15; 82(12):2254-2268.
-
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Lett. 2022 07 28; 539:215722.
-
Pancreatic Ductal Cell-Derived Extracellular Vesicles Are Effective Drug Carriers to Enhance Paclitaxel's Efficacy in Pancreatic Cancer Cells through Clathrin-Mediated Endocytosis. Int J Mol Sci. 2022 Apr 26; 23(9).
-
The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells. Nucleic Acids Res. 2022 04 08; 50(6):3394-3412.
-
A Novel Translational Activation of HIF1a Promotes Pancreatic Cancer Growth Through Glycolytic Reprogramming. Gastroenterology. 2022 04; 162(4):1040-1042.
-
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling. Sci Rep. 2022 01 31; 12(1):1659.